Gebski Christine
SEC CIK 1849585 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | See Remarks | 27.4K | — | $2.34M | 19 | 2021-09-01 | 2024-05-14 |
Most active insiders at RGEN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hunt Anthony | Dir | — | $7.01M |
| 2 | Loeillot Olivier | CEO, Dir | — | $4.19M |
| 3 | Bylund James | COO | — | $331.3K |
| 4 | Garland Jason K | CFO | — | $185.8K |
| 5 | DAWES KAREN A | Dir | — | $44.3K |
| 6 | Douglass Brian Robb | Chief PRODUCT Off | — | — |
| 7 | Pax Margaret | Dir | — | — |
| 8 | Hughes Violetta | CAO | — | — |
| 9 | Mhatre Rohin | Dir | — | — |
| 10 | Konstantinov Konstantin | Dir | — | — |
Gebski Christine made no open-market trades at RGEN in the last 12 months.
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-15 | 2024-05-14 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $163.34 | -334 | 27.4K | -1% | -$54.6K | |
| 2024-03-07 | 2024-03-07 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $195.72 | -386 | 27.8K | -1% | -$75.5K | |
| 2024-03-06 | 2024-03-04 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $193.99 | -131 | 28.1K | -0.5% | -$25.4K | |
| M | 2024-03-04 | 2024-03-01+ | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $192.26 | -908 | 28.7K | -3% | -$174.6K |
| 2024-03-04 | 2024-02-29 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | A - Grant | $0.00 | +391 | 29.2K | +1% | $0 | |
| 2023-11-13 | 2023-11-10 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | S - Sale | $147.13 | -3,788 | 28.8K | -12% | -$557.3K | |
| 2023-05-16 | 2023-05-16 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $154.03 | -334 | 32.6K | -1% | -$51.4K | |
| DM | 2023-03-06 | 2023-03-02+ | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | A - Grant | $0.00 | +3,842 | 32.7K | +13% | $0 |
| D | 2023-03-06 | 2023-03-03 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $188.00 | -126 | 32.9K | -0.4% | -$23.7K |
| M | 2023-03-02 | 2023-02-28+ | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $173.91 | -1,090 | 29.8K | -4% | -$189.6K |
| 2023-02-28 | 2023-02-28 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $173.44 | -452 | 30.3K | -1% | -$78.4K | |
| 2022-08-05 | 2022-08-04 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | S - Sale | $243.01 | -3,357 | 30.7K | -10% | -$815.8K | |
| 2022-05-17 | 2022-05-13 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $150.40 | -335 | 34.1K | -1.0% | -$50.4K | |
| M | 2022-03-02 | 2022-02-27+ | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $196.70 | -1,060 | 34.4K | -3% | -$208.5K |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $189.21 | -181 | 35.5K | -0.5% | -$34.2K |
| D | 2022-02-28 | 2022-02-24 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | A - Grant | $0.00 | +2,124 | 35.7K | +6% | $0 |
| 2022-02-22 | 2022-02-17 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | A - Grant | $0.00 | +450 | 33.8K | +1% | $0 | |
| 2022-02-22 | 2022-02-17 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | F - Tax | $182.42 | -224 | 33.5K | -0.7% | -$40.9K | |
| 2021-09-02 | 2021-09-01 | RGEN | REPLIGEN CORP | Gebski Christine | See Remarks | S - Sale | $285.33 | -3,377 | 33.3K | -9% | -$963.6K |
Purchase Sale Sale after option exercise All abbreviations